Literature DB >> 10078781

Ecological effect of gatifloxacin on the normal human intestinal microflora.

C Edlund1, C E Nord.   

Abstract

Gatifloxacin, a new broad-spectrum fluoroquinolone, was given in oral doses of 400 mg once daily for 10 days to 18 healthy volunteers, in order to study the impact on the normal intestinal microflora. Fecal samples were collected prior to administration (Day -4 and Day -1), during the administration period (Day 5 and 10) and after withdrawal of administration (Day 12, 16, 22, 30 and 50). In the aerobic intestinal microflora Escherichia coli strains were eliminated or strongly suppressed during the administration period and the numbers of enterococci decreased significantly while the numbers of staphylococci increased at the same time. In the anaerobic microflora the numbers of clostridia and fusobacteria decreased significantly during the administration period while no other major changes occurred. The microflora was normalized 40 days after the administration of gatifloxacin had stopped. No selection or overgrowth of resistant bacterial strains or yeasts occurred. The ecological impact of gatifloxacin was shown to be selective and similar to that of quinolones like ciprofloxacin, levofloxacin and ofloxacin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078781     DOI: 10.1179/joc.1999.11.1.50

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  5 in total

Review 1.  Gatifloxacin: a review of its use in the management of bacterial infections.

Authors:  Caroline M Perry; Douglas Ormrod; Miriam Hurst; Susan V Onrust
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Effect of quinolones on intestinal ecology.

Authors:  C Edlund; C E Nord
Journal:  Drugs       Date:  1999       Impact factor: 9.546

3.  Effect of parenteral fluoroquinolone administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.

Authors:  Curtis J Donskey; Marion S Helfand; Nicole J Pultz; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 4.  Human gut microbiota: repertoire and variations.

Authors:  Jean-Christophe Lagier; Matthieu Million; Perrine Hugon; Fabrice Armougom; Didier Raoult
Journal:  Front Cell Infect Microbiol       Date:  2012-11-02       Impact factor: 5.293

5.  Effects of treatment with antimicrobial agents on the human colonic microflora.

Authors:  Fatemeh Rafii; John B Sutherland; Carl E Cerniglia
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.